Table of Contents

company-logo

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

VYNE Therapeutics Dividend Announcement

• VYNE Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on VYNE Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

VYNE Therapeutics Dividend History

VYNE Therapeutics Dividend Yield

VYNE Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing VYNE Therapeutics stock? Use our calculator to estimate your expected dividend yield:

VYNE Therapeutics Financial Ratios

P/E ratio-3.70
PEG ratio-0.53
P/B ratio1.98
ROE-43.77%
Payout ratio0.00%
Current ratio5.81
Quick ratio5.81
Cash Ratio1.29

VYNE Therapeutics Dividend FAQ

Does VYNE Therapeutics stock pay dividends?
VYNE Therapeutics does not currently pay dividends to its shareholders.
Has VYNE Therapeutics ever paid a dividend?
No, VYNE Therapeutics has no a history of paying dividends to its shareholders. VYNE Therapeutics is not known for its dividend payments.
Why doesn't VYNE Therapeutics pay dividends?
There are several potential reasons why VYNE Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will VYNE Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While VYNE Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is VYNE Therapeutics a dividend aristocrat?
VYNE Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is VYNE Therapeutics a dividend king?
VYNE Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is VYNE Therapeutics a dividend stock?
No, VYNE Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy VYNE Therapeutics stocks?
To buy VYNE Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy VYNE Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.